Thrivent Financial for Lutherans
NVO

Thrivent Financial for Lutherans’s Novo Nordisk NVO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+4,460
New +$192K ﹤0.01% 2541
2026
Q1 		– Sell
-20,217
Closed -$1.03M – 2635
2025
Q4 		$1.03M Sell
20,217
-689
-3% -$35.2K ﹤0.01% 1914
2025
Q3 		$1.16M Sell
20,906
-24,224
-54% -$1.42M ﹤0.01% 1695
2025
Q2 		$3.1M Sell
45,130
-2,769
-6% -$188K 0.01% 1068
2025
Q1 		$5.21M Sell
47,899
-72,736
-60% -$6.01M 0.01% 819
2024
Q4 		$11.5M Sell
120,635
-8,965
-7% -$969K 0.02% 613
2024
Q3 		$15.4M Sell
129,600
-660,825
-84% -$88.1M 0.03% 540
2024
Q2 		$113M Sell
790,425
-545,344
-41% -$72.3M 0.23% 101
2024
Q1 		$172M Sell
1,335,769
-67,624
-5% -$8.05M 0.34% 53
2023
Q4 		$145M Buy
1,403,393
+359,798
+34% +$35.6M 0.32% 64
2023
Q3 		$94.9M Buy
1,043,595
+451,797
+76% +$39.8M 0.23% 123
2023
Q2 		$47.9M Buy
591,798
+15,458
+3% +$1.26M 0.11% 242
2023
Q1 		$45.9M Sell
576,340
-461,290
-44% -$32.7M 0.11% 238
2022
Q4 		$70.2M Sell
1,037,630
-507,742
-33% -$29.8M 0.18% 156
2022
Q3 		$77M Buy
1,545,372
+133,572
+9% +$7.16M 0.21% 125
2022
Q2 		$78.7M Sell
1,411,800
-291,392
-17% -$16.2M 0.21% 120
2022
Q1 		$94.6M Buy
1,703,192
+60,052
+4% +$3.08M 0.19% 136
2021
Q4 		$92M Buy
1,643,140
+299,794
+22% +$16.2M 0.18% 146
2021
Q3 		$64.5M Sell
1,343,346
-454,168
-25% -$22M 0.13% 193
2021
Q2 		$75.3M Buy
1,797,514
+78,076
+5% +$3.03M 0.15% 168
2021
Q1 		$58M Buy
1,719,438
+133,402
+8% +$4.75M 0.13% 200
2020
Q4 		$55.4M Buy
1,586,036
+122,136
+8% +$4.22M 0.13% 198
2020
Q3 		$50.8M Buy
1,463,900
+12,812
+0.9% +$427K 0.14% 184
2020
Q2 		$47.5M Buy
+1,451,088
New +$46.3M 0.14% 175
2013
Q3 		– Sell
-13,000
Closed -$201K – 1584
2013
Q2 		$201K Buy
+13,000
New +$216K ﹤0.01% 1438

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Thrivent Financial for Lutherans's NVO Position: Q2 2026 in Review

Thrivent Financial for Lutherans opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,460 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #2541 among its holdings. This is a return to the name: Thrivent Financial for Lutherans previously reported a position in NVO as recently as Q4 2025.

Thrivent Financial for Lutherans first reported a position in NVO in Q2 2013 and has held it in 25 quarters since. The position peaked at $172M in Q1 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Thrivent Financial for Lutherans held 4,460 shares of Novo Nordisk worth $214K as of Q2 2026.
  • Novo Nordisk was a new Thrivent Financial for Lutherans position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2541 holding.
  • Thrivent Financial for Lutherans first reported a position in Novo Nordisk in Q2 2013 and has held it in 25 quarters since.
  • Thrivent Financial for Lutherans's Novo Nordisk position peaked at $172M in Q1 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.